Tissue
set
Antigen
SET
Form/Appearance
N/A
Concentration
1mg/ml
French translation
anticorps
Gene name
SET ; SET
Category
Antibodies
Clonality
Polyclonal Antibodies
Purification method
Affinity Purification
Long name
SET Polyclonal Antibody
Clone
Not applicable to Polyclonal Antibodies
Applications
Western Blot (WB), Immunohistochemistry (IHC)
Specificity
This is an antibody designed to detect SET ; SET
Synonim names
2PP2A; IGAAD; TAF-I; I2PP2A; IPP2A2; PHAPII; TAF-IBETA
Reacts with
Human (Homo sapiens), Mouse (Mus musculus), Rat (Rattus norvegicus)
Gene synonims
SET; SET; 2PP2A; IGAAD; TAF-I; I2PP2A; IPP2A2; PHAPII; TAF-IBETA; IGAAD; I-2PP2A; TAF-I
Properties
If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
Description
This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.Antibody for research use.
Storage, shipping and handling
The antibody is shipped at +4 degrees Celsius. Upon receving, freeze at -20. For longer periods of time we recommend keeping the vial frozen at -40 or -80. Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody. Due to transportation or handling reasons, small amounts of the antibody might get caught on the lid or walls of the vial. We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom.
Other names
Protein SET; Protein SET; protein SET; SET nuclear oncogene; HLA-DR-associated protein II; phosphatase 2A inhibitor I2PP2A; inhibitor-2 of protein phosphatase-2A; protein phosphatase type 2A inhibitor; inhibitor of granzyme A-activated DNase; SET translocation (myeloid leukemia-associated); Template-Activating Factor-I, chromatin remodelling factor; SET nuclear proto-oncogene; HLA-DR-associated protein II; Inhibitor of granzyme A-activated DNase; IGAAD; PHAPII; Phosphatase 2A inhibitor I2PP2A; I-2PP2A; Template-activating factor I; TAF-I